Major Israeli hospitals treating neuroblastoma include Sheba Medical Center, Sourasky (Ichilov), Hadassah, Rambam, and Schneider Children's. These facilities hold Joint Commission International (JCI) accreditation. Leading specialists include Dr. Hana Golan and Prof. Ronit El Hasid, who follow international high-risk protocols and utilize bone marrow transplantation.
- Sheba Medical Center: Ranked 7th globally in 2026 with JCI and ISO certifications.
- Sourasky (Ichilov) Center: Reports a 90% success rate for pediatric oncology treatments.
- Specialist credentials: Dr. Hana Golan leads international ESIOP high-risk neuroblastoma protocols.
- Advanced therapies: Centers offer MIBG therapy, CAR-T cell therapy, and stem cell rescue.
Bookimed Expert Insight: Israeli medical centers demonstrate a significant scale of care, with Sheba Medical Center alone treating over 2 million patients annually. Our data shows that top-tier packages, such as those at Sheba, priced around $160,000 for complex bone marrow transplants, often include 30 hospital days. This extensive inpatient stay is a key differentiator compared to clinics in other regions that may offer shorter initial monitoring periods.
Patient Consensus: Parents emphasize the importance of contacting international coordinators early to manage visas and translations. Families note that while surgical success is high, navigating language barriers is easier when using the dedicated international wings of major centers like Sourasky.